Mutation in SNAP25 as a novel genetic cause of epilepsy and intellectual disability

• Published in: Rare diseases (Austin, Tex.) Vol. 1; no. 1; p. e26314
• Main Authors: Rohena, Luis, Neidich, Julie, Truitt Cho, Megan, Gonzalez, Kelly DF, Tang, Sha, Devinsky, Orrin, Chung, Wendy K
• Format: Journal Article
• Language: English
• Published: United States Taylor & Francis 01.01.2013; Landes Bioscience
• Subjects: epilepsy; intellectual disability; novel mutation; Research Paper; SNAP25; whole exome sequencing; epilepsy; SNAP25; novel mutation; intellectual disability; whole exome sequencing
• ISSN: 2167-5511; 2167-5511
• DOI: 10.4161/rdis.26314

Whole exome sequencing using a parent-child trio design to identify de novo mutations provides an efficient method to identify novel genes for rare diseases with low reproductive fitness that are difficult to study by more classical genetic methods of linkage analysis. We describe a 15 y old female with severe static encephalopathy, intellectual disability, and generalized epilepsy. After extensive metabolic and genetic testing, whole exome sequencing identified a novel de novo variant in Synaptosomal-associated protein-25 (SNAP25), c.142G > T p.Phe48Val alteration. This variant is predicted to be damaging by all prediction algorithms. SNAP25 is part of the soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) protein complex which is involved in exocytotic release of neurotransmitters. Genetic alterations in Snap25 in animal models can cause anxiety-related behavior, ataxia and seizures. We suggest that SNAP25 mutations in humans are a novel genetic cause of intellectual disability and epilepsy.